Related Experiment Video

Updated: Mar 15, 2026

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells
06:40

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

17.3K

Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching

Laurence Borgs1, Elise Peyre1, Philippe Alix1

  • 1GIGA-Research, GIGA-Neurosciences, Université de Liège, Belgium.

Scientific Reports
|September 20, 2016
PubMed

Insights

Mutations in the LRRK2 gene, like G2019S, are linked to Parkinson's disease (PD). This study modeled PD using patient stem cells, revealing impaired dopaminergic neuron development and branching defects.

Area of Science:

  • Neuroscience
  • Genetics
  • Stem Cell Biology

Background:

  • Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene are a significant cause of autosomal dominant Parkinson's disease (PD).
  • The G2019S mutation is the most common LRRK2 mutation, accounting for approximately 2% of all PD cases.
  • Understanding the cellular and molecular mechanisms underlying LRRK2-associated PD is crucial for developing effective therapies.

Purpose of the Study:

  • To develop an in vitro model of Parkinson's disease using patient-derived induced pluripotent stem cells (hiPSCs).
  • To investigate the impact of the LRRK2 G2019S mutation on neural stem cell differentiation and dopaminergic neuron development.
  • To explore potential developmental implications of the LRRK2 G2019S mutation in the context of PD pathophysiology.

Main Methods:

  • Reprogramming of skin fibroblasts from PD patients with the LRRK2 G2019S mutation into hiPSCs.
  • Directed differentiation of hiPSCs into neural stem cells (NSCs).
  • Further differentiation of NSCs into dopaminergic neurons for comparative analysis.

Main Results:

  • NSCs carrying the LRRK2 G2019S mutation demonstrated reduced efficiency in differentiating into dopaminergic neurons compared to controls.
  • Dopaminergic neurons derived from G2019S mutation-carrying hiPSCs exhibited significant neurite branching defects.
  • These findings suggest a cell-intrinsic defect in neurodevelopment associated with the LRRK2 G2019S mutation.

Conclusions:

  • The in vitro model effectively recapitulates aspects of LRRK2-associated Parkinson's disease.
  • The LRRK2 G2019S mutation impairs the differentiation potential of neural stem cells and the maturation of dopaminergic neurons.
  • This study highlights potential developmental contributions to Parkinson's disease pathogenesis in the context of LRRK2 mutations.

More Related Videos

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies12:13

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

7.7K
Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring09:34

Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring

Published on: August 6, 2020

7.9K

Related Concept Videos

EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.4K